PRNewswire

First scientific presentation of previously announced data from Cohort 1 of the ongoing Phase 1b clinical trial evaluating low-dose LTI-03 (2.5 mg BID) in IPF, affirms positive trends in seven of the eight biomarkers evaluated, suggesting potential therapeutic effect Recently completed enrollment of

CHANGJI, China, Oct. 12, 2024 /PRNewswire/ — Recently, as the 2024 heating season has commenced, to ensure residents enjoy clean and warm heating through the winter, on October 9th, members of the service team from the Xinjiang Changji Electric Power Supply Company, Wang Zhenpeng and Li Yong,

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: